Supermax is also in the business of masks, sanitizers and face shield. All of these are also in great demand for the many years ahead.

You naysayers are obviously parasites with your manipulation. Karma will always be there to balance this out.

gnath_77, MoneyMaker and all naysayers - We glove supporters believe in Fundamentals. Not your manipulation.

The Big 4 Glove companies have donated RM 400 Mil to the Malaysian Government for the vaccination. Not to mention the huge tax paid through the profits.

Their generosity will be valued and remembered. Do good out there and good will come back. That's the law of the Universe.

So no matter what you say, we believe in the good. We believe in glove companies. We believe in the true Malaysian product. As Malaysians, we support our own success in the world.

gnath_77 - Why are you still here in this forum if negative about Supermax. You are probably working for the IBs in manipulating the share price.

@dumbdumb123 - truly is dumb dumb.

Read the 3Q and 4Q reports yourselves.

The facts and numbers do not lie. Obviously your Math is also dumb dumb LOL.

vaccine is the catalyst for glove. Its the IBs that are trying to kill gloves through their manipulation. LOL

gnath_77 - Its IB manipulation. If not it will skyrocket back to new heights. MIDF TP RM 13+.

All naysayers are aware of this and that is why they are buying cheap.

Pfizer vaccine requires 2 X doses within 21 - 28 days. Next will be a booster 3 dose to combat the virus variant. This will continue whenever there is a new variant. So vaccination will be continuous over many many years. Glove demand will continue for many years to come.

Health workers all around the world are using gloves because of the new variant. Also transmission of other infections like HIV.

Would you want a health worker to give you or you family a jab after he / she has given a jab to a HIV positive patient without wearing gloves?

Not sellers are right. Its IB and RSS manipulation LOL

@rr8 and glovefinish - put your money where your mouth is. Go volunteer to expose yourself to the South African virus variant with Pfizer vaccine. They are looking for test subjects. Take your whole family as well if you belief this is the cure.

Naysayers - If you are negative about glove companies, then why are you still here?

@ MoneyMaker

First of all its 6% increase in revenue in 1 quarter

Second they had to shut down for roughly 2-3 weeks in Q4'20 due to the Covid infection at the plant. Yet their revenue increased by 6%. If not for the plant shut down, revenue would be well above 10%.

3rd, with ASPs continually rising, the coming Q1'21 results will show a very big jump from Q4'20 numbers and this cld be announced as early as end Apr'21.

4th, they are now running 30 lines with an annual capacity of 4.86 billion pieces of gloves. By mid of June 2021, they should complete installation of 10 lines and another eight lines by the end of 2021, with an addition of nine lines in the planning stage to be completed by the end of 2022.

As a result, the group will have 57 production lines with an annual capacity of 10.5 billion pieces of medical and surgical gloves by end 2022

They have also put in place an increase surgical gloves packing facilities from 72 million pairs to 288 million pairs annually by end 2021.

@ emsvsi and investmalaysia8 and all naysayers

Know the facts before you comment.

Careplus 3Q20 PAT RM 42.9 Mil included the one-off gain of RM 15.4 Mil from the disposal of 50% equity interest in Careplus for the joint venture with Ansell in the last year second quarter.

So its actual 3Q20 PAT from just glove revenue was RM 42.9 - RM 15.4 = RM 27.5 Mil.

4Q20 PAT from just glove revenue is RM 42.2 Mil.

Now do the math. An increase of PAT RM 14.7 Mil in just one quarter. A whooping +53% increase in PAT from glove revenue.

So very clear indication that Average Selling Price has indeed gone up significantly. The numbers do not lie. These are the facts. The glove peak is yet to come.

So emsvsi and investmalaysia8 and all naysayers - best to revisit your maths lessons and your false sanity.

Also Reading the notes to the Q4'20 report, there are one-off provisions and expenses recognised in this Q4 of RM21.64m.

Adding that back to the PBT of RM59.5m, Q4 PBT wld have been RM81.1M, a big jump from Q3'20 PBT of RM49.7m.

As such, and with ASPs continually rising, the coming Q1'21 results should show a very big jump from Q4'20 numbers and this cld be announced as early as end Apr'21.

Prospects (as per the 4th Quarter Ended 31 December 2020 )

Also Reading the notes to the Q4'20 report, there are one-off provisions and expenses recognised in this Q4 of RM21.64m.

Adding that back to the PBT of RM59.5m, Q4 PBT wld have been RM81.1M, a big jump from Q3'20 PBT of RM49.7m.

As such, and with ASPs continually rising, the coming Q1'21 results should show a very big jump from Q4'20 numbers and this cld be announced as early as end Apr'21.

Prospects (as per the 4th Quarter Ended 31 December 2020 )

Careplus 3Q20 PAT RM 42.9 Mil included the one-off gain of RM 15.4 Mil from the disposal of 50% equity interest in Careplus for the joint venture with Ansell in the last year second quarter.

So its actual 3Q20 PAT from just glove revenue was RM 42.9 - RM 15.4 = RM 27.5 Mil.

4Q20 PAT from just glove revenue is RM 42.2 Mil.

Now do the math. An increase of PAT RM 14.7 Mil in just one quarter. A whooping +53% increase in PAT from glove revenue.

So very clear indication that Average Selling Price has indeed gone up significantly. The numbers do not lie. These are the facts. The glove peak is yet to come.

Careplus 3Q20 PAT RM 42.9 Mil included the one-off gain of RM 15.4 Mil from the disposal of 50% equity interest in Careplus for the joint venture with Ansell in the last year second quarter.

So its actual 3Q20 PAT from just glove revenue was RM 42.9 - RM 15.4 = RM 27.5 Mil.

4Q20 PAT from just glove revenue is RM 42.2 Mil.

Now do the math. An increase of PAT RM 14.7 Mil in just one quarter. A whooping +53% increase in PAT from glove revenue.

So very clear indication that Average Selling Price has indeed gone up significantly. The numbers do not lie. These are the facts. The glove peak is yet to come.

Also Reading the notes to the Q4'20 report, there are one-off provisions and expenses recognised in this Q4 of RM21.64m.

Adding that back to the PBT of RM59.5m, Q4 PBT wld have been RM81.1M, a big jump from Q3'20 PBT of RM49.7m.

As such, and with ASPs continually rising, the coming Q1'21 results should show a very big jump from Q4'20 numbers and this cld be announced as early as end Apr'21.

Prospects (as per the 4th Quarter Ended 31 December 2020 )

Careplus 3Q20 PAT RM 42.9 Mil included the one-off gain of RM 15.4 Mil from the disposal of 50% equity interest in Careplus for the joint venture with Ansell in the last year second quarter.

So its actual 3Q20 PAT from just glove revenue was RM 42.9 - RM 15.4 = RM 27.5 Mil.

4Q20 PAT from just glove revenue is RM 42.2 Mil.

Now do the math. An increase of PAT RM 14.7 Mil in just one quarter. A whooping +53% increase in PAT from glove revenue.

So very clear indication that Average Selling Price has indeed gone up significantly. The numbers do not lie. These are the facts. The glove peak is yet to come.

Careplus 3Q20 PAT RM 42.9 Mil included the one-off gain of RM 15.4 Mil from the disposal of 50% equity interest in Careplus for the joint venture with Ansell in the last year second quarter.

So its actual 3Q20 PAT from just glove revenue was RM 42.9 - RM 15.4 = RM 27.5 Mil.

4Q20 PAT from just glove revenue is RM 42.2 Mil.

Now do the math. An increase of PAT RM 14.7 Mil in just one quarter. A whooping +53% increase in PAT from glove revenue.

So very clear indication that Average Selling Price has indeed gone up significantly. The numbers do not lie. These are the facts. The glove peak is yet to come.

Also Reading the notes to the Q4'20 report, there are one-off provisions and expenses recognised in this Q4 of RM21.64m.

Adding that back to the PBT of RM59.5m, Q4 PBT wld have been RM81.1M, a big jump from Q3'20 PBT of RM49.7m.

As such, and with ASPs continually rising, the coming Q1'21 results should show a very big jump from Q4'20 numbers and this cld be announced as early as end Apr'21.

Prospects (as per the 4th Quarter Ended 31 December 2020 )

That is why the Edge Market used the word "skyrocketed".

@ emsvsi and idunwork and all naysayers

Know the facts before you comment.

Careplus 3Q20 PAT RM 42.9 Mil included the one-off gain of RM 15.4 Mil from the disposal of 50% equity interest in Careplus for the joint venture with Ansell in the last year second quarter.

So its actual 3Q20 PAT from just glove revenue was RM 42.9 - RM 15.4 = RM 27.5 Mil.

4Q20 PAT from just glove revenue is RM 42.2 Mil.

Now do the math. An increase of PAT RM 14.7 Mil in just one quarter. A whooping +53% increase in PAT from glove revenue.

So very clear indication that Average Selling Price has indeed gone up significantly. The numbers do not lie. These are the facts. The glove peak is yet to come.

So emsvsi and idunwork and all naysayers - best to revisit your maths lessons and your false sanity.

https://www.theedgemarkets.com/article/careplus-4q-net-profit-skyrockets-rm42m-declares-two-sen-special-dividend

February 19, 2021 21:43 pm +08

Careplus Group Bhd’s net profit for the fourth quarter ended Dec 31, 2020 (4QFY20) skyrocketed to RM42.23 million from RM783,000 a year earlier boosted by higher selling prices and strong demand.

Earnings per share ballooned to 7.87 sen from 0.15 sen in 4QFY19.

https://www.theedgemarkets.com/article/careplus-4q-net-profit-skyrockets-rm42m-declares-two-sen-special-dividend

February 19, 2021 21:43 pm +08

Careplus Group Bhd’s net profit for the fourth quarter ended Dec 31, 2020 (4QFY20) skyrocketed to RM42.23 million from RM783,000 a year earlier boosted by higher selling prices and strong demand.

Earnings per share ballooned to 7.87 sen from 0.15 sen in 4QFY19.

No worries we are ready to pick up more shares at lower price. After next week, we will reap our harvest. So please continue to press lower.

IBs without Warrants give a fair TP.

IBs with warrants keep lowering the TP because they suffer huge losses in the warrants if TP is higher. So they manipulate.

TomYam, you missed out MIDF - Supermax TP: RM13.83. Dated 18 Feb 2021.

Its not the vaccine. In fact Vaccine is the catalyst. Its the IBs manipulating the share price and using naysayers to create selling pressure. LOL

To all the naysayers, why are you still here if no hope. For one reason, to manipulate for IBs. We all know who you are. We have the patients to wait. Only gloves has billions of PAT, for many years to come.

Here you go. From MIDF.

https://www.bernama.com/en/news.php?id=1932733

Rubber gloves, MIDF Research, ASP, vaccine, COVID-19, export. ... Glove (TP: RM8.29), Kossan (TP: RM7.33) and Supermax (TP: RM13.83).

GroundZero, if Supermax is a rubbish counter, then why are you still here?

Go volunteer to be the test subject for the South African variant.

Its the naysayers that are not truthful and have evil intentions. Why are you still in this forum if you are negative of Supermax. Way waste your time. Its because you all work for the interest of IBs.

Here you go, to all naysayers.

https://globalnews.ca/news/7649886/coronavirus-japan-new-variant/

All my postings are factual.

Japan has reported 151 cases of variants from Britain, South Africa and Brazil, according to the health ministry. The nation has had more than 400,000 cases of COVID-19 with 7,194 fatalities.

The only reason for red all these days is nothing to do with Vaccine. It has everything to do with IB warrants expiring next week 26 Feb. These has been a lot of fake que to sell and RSS borrowing. Many are buying cheap and collecting. After next week, once all IBs have been burnts in millions, the share price will skyrocket. Especially when Supermax releases the good news about its business in the USA.

Not worried at all. Supermax will shoot very soon.

Why no response from MoneyMaker or all the other naysayers?
Put your money where your mouth is. Volunteer to be the test subjects for the Vaccine companies and then expose yourselves to the variant viruses - the South African, UK and USA variant. Or are you all just "All Talk" only.

Israel not exposed yet to the South African Variant or UK Variant or new US Variant yet. When they open up their lockdown, then you will see the real acid test. The Scientist and the WHO has already warn the World.

https://www.businessinsider.com/pfizer-biontech-vaccine-south-africa-variant-covid-vaccines-mutation-2021-2

The vaccines, however, showed a decreased ability to neutralize the strain now dominant in South Africa, worrying some researchers and prompting Pfizer and BioNTech to announce they were taking necessary steps to develop a booster shot or updated vaccine. A day after Pfizer’s announcement, a top White House coronavirus adviser said each vaccine developer is planning to update shots to address variants.

MoneyMaker - Do you dare to get infected by the South African Variant and then take the Pfizer Vaccine? Maybe you should volunteer to be the test subject. Put your money where your mouth is.

https://www.businessinsider.com/pfizer-biontech-vaccine-south-africa-variant-covid-vaccines-mutation-2021-2

Pfizer-BioNTech's COVID-19 vaccine produces a much weaker immune response against the variant found in South Africa, a new study suggests
There was approximately a two-third reduction in how well antibodies produced by Pfizer's vaccine fought against a lab-made variant, according to correspondence published in the New England Journal of Medicine.
The lab-made variant had the exact same spike protein — the part of the virus that it uses to infect cells, and the target for existing COVID-19 vaccines — as the variant, which has now been found in 35 countries and multiple US states.
The variant is thought to be 50% more contagious than original coronavirus variants.

MoneyMaker, read all the reports for yourself. No time to waste on your games.

Israel not exposed yet to the South African Variant or UK Variant or new US Variant yet. When they open up their lockdown, then you will see the real acid test. The Scientist and the WHO has already warn the World.

MoneyMaker is still living under a coconut shell.

Scientist and WHO know better that you. They are the professionals. Not YOU.

No. Your are wrong. Only 33% effectiveness. So when you are infected with this Variant and if mild then you do not need hospitalization. But when moderate or severe infection, you can die if not hospitalised. That is why South Africa has stopped the AstraZeneca vaccinations. And Brazil has stopped the China vaccine.

Get your fact right.

https://www.theedgemarkets.com/article/pfizer-study-deals-new-blow-sou...


February 18, 2021 22:28 pm +08
Pfizer study deals new blow to South Africa's vaccine hopes
reduce antibody protection from Pfizer's Covid-19 vaccine by two-thirds. Which means only 33.33% effective.

AstraZeneca vaccinations also not effective against the South African Virus.

So due to Virus Variant, new booster vaccines will be developed and more vaccinations around the world. This will be a ANNUAL affair. Exponential glove demand every Year.

http://www.xinhuanet.com/english/2021-02/18/c_139748689.htm

2021-Feb-18 04:11:11

EU launches bio-defense preparedness plan against COVID-19 variants


The EU will spend 75 million euros (90.3 million U.S. dollars) on detecting, analyzing and assessing virus variants by supporting genomic sequencing in its member states, and a further 150 million euros on stepping up research and data exchange on variants, according to the Commission.
Mechanisms have also been devised to improve clinical trials and ramp up the production of COVID-19 vaccines.
The actions, the Commission said, are in preparation for the European Health Emergency Preparedness and Response Authority (HERA), which will be a permanent structure for risk modeling, global surveillance, technology transfers, supply chain risk mapping, flexible manufacturing, and vaccine and medicine research and development. Enditem

So due to Virus Variant, new booster vaccines will be developed and more vaccinations around the world. This will be a ANNUAL affair. Exponential glove demand every Year.

http://www.xinhuanet.com/english/2021-02/18/c_139748689.htm

2021-Feb-18 04:11:11

EU launches bio-defense preparedness plan against COVID-19 variants


The EU will spend 75 million euros (90.3 million U.S. dollars) on detecting, analyzing and assessing virus variants by supporting genomic sequencing in its member states, and a further 150 million euros on stepping up research and data exchange on variants, according to the Commission.
Mechanisms have also been devised to improve clinical trials and ramp up the production of COVID-19 vaccines.
The actions, the Commission said, are in preparation for the European Health Emergency Preparedness and Response Authority (HERA), which will be a permanent structure for risk modeling, global surveillance, technology transfers, supply chain risk mapping, flexible manufacturing, and vaccine and medicine research and development. Enditem

So due to Virus Variant, new booster vaccines will be developed and more vaccinations around the world. This will be a ANNUAL affair. Exponential glove demand every Year.

https://edition.cnn.com/world/live-news/coronavirus-pandemic-vaccine-updates-02-18-21/index.html
Updated 6:19 p.m. ET, February 18, 2021

The coronavirus variant first identified in the UK has now been found in 94 countries. The variant first identified in South Africa has been found in 46 countries, and the variant first identified in Brazil in 21, WHO said.

So due to Virus Variant, new booster vaccines will be developed and more vaccinations around the world. This will be a ANNUAL affair. Exponential glove demand every Year.

https://edition.cnn.com/world/live-news/coronavirus-pandemic-vaccine-updates-02-18-21/index.html
Updated 6:19 p.m. ET, February 18, 2021

The coronavirus variant first identified in the UK has now been found in 94 countries. The variant first identified in South Africa has been found in 46 countries, and the variant first identified in Brazil in 21, WHO said.

So due to Virus Variant, new booster vaccines will be developed and more vaccinations around the world. This will be a ANNUAL affair. Exponential glove demand every Year.